Table 2.
PAD Patients |
Healthy Subjects |
|||
---|---|---|---|---|
Preketorolac | Postketorolac | Preketorolac | Postketorolac | |
Thromboxane B2, pg/ml | 120 ± 28† | 84 ± 4 | 714 ± 32 | 232 ± 3* |
6-Keto-PGF1α, pg/ml | 88 ± 8† | 87 ± 7 | 137 ± 88 | 22 ± 6* |
Values are means ± SE; n = 7 PAD patients and 7 healthy control subjects.
Difference between preketorolac and postketorolac in healthy subjects; †difference between groups at the specific time point (P < 0.05).